세계 융합 단백질 시장 규모는 2025년 363억 달러에서 2025년부터 2030년까지 CAGR 12.3%로 성장하여 2030년 말에는 649억 달러 규모로 성장할 것으로 예상됩니다.
북미 시장은 2025년 133억 달러에서 2030년 말에는 229억 달러에 달할 것으로 예상되며, 2025년부터 2030년까지 11.6%의 CAGR을 기록할 것으로 전망됩니다. 아시아태평양 시장은 2025년 90억 달러에서 2025년부터 2030년까지 14.5%의 CAGR로 성장하여 2030년 말에는 176억 달러에 달할 것으로 예상됩니다.
세계의 융합 단백질 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추정 및 예측, 각종 부문별·지역별 상세 분석 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
시장 전망
조사 범위
시장 요약
시장 역학과 성장 촉진요인
신기술
부문 분석
지역 분석
결론
제2장 시장 개요
개요
기술적 배경
Fc 융합 단백질의 이점
Porter's Five Forces 분석
거시경제 요인 분석
미국 관세의 영향
약가에 관한 정부 정책
지정학적 요인
제3장 시장 역학
시장 역학
시장 성장 촉진요인
기존 단백질 의약품 약동학 및 약력학적 특성의 개선 필요성
표적 치료제 수요
시장 성장 억제요인
제조상 과제
부작용과 면역원성 리스크
시장 기회
융합 단백질 진단에 대한 응용
적응 확대와 장기간 작용형 의약품
제4장 신기술과 파이프라인 분석
중요 포인트
신기술
항체 지향형 효소 전구체 치료
융합 단백질 공학을 위한 AI
암 치료를 위한 이중 기능 융합 단백질
파이프라인 분석
제5장 시장 세분화 분석
부문별 내역
시장 분석 : 리간드 유형별
중요 포인트
사이토카인 트랩
펩타이드 기반 융합 단백질
수용체 기반 융합 단백질
기타
시장 분석 : 투여 경로별
중요 포인트
피하
유리체내
정맥내
기타
시장 분석 : 용도별
중요 포인트
안과 질환
자가면역질환
대사장애
혈액질환
기타
지역적 내역
시장 분석 : 지역별
중요 포인트
북미
유럽
아시아태평양
세계 기타 지역
제6장 경쟁 정보
중요 포인트
업계 구조
기업 점유율 분석
전략 분석
제7장 융합 단백질 시장의 지속가능성 : ESG 관점
ESG : 소개
ESG 리스크 평가
결론
제8장 부록
조사 방법
정보 출처
두문자어
기업 개요
AMGEN INC.
ASTRAZENECA
BAYER AG
BRISTOL-MYERS SQUIBB CO.
EVIVE BIOTECH
F. HOFFMANN-LA ROCHE LTD.
KINIKSA PHARMACEUTICALS
LILLY USA LLC.
MERCK & CO. INC.
PFIZER INC.
REGENERON PHARMACEUTICALS INC.
REMEGEN
SAMSUNG BIOEPIS
SANDOZ GROUP AG
SANOFI
신흥 스타트업/시장 파괴자
KSM
영문 목차
영문목차
The global market for fusion proteins is expected to grow from $36.3 billion in 2025 to reach $64.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2030.
The North American market for fusion proteins is expected to grow from $13.3 billion in 2025 to reach $22.9 billion by the end of 2030, at a CAGR of 11.6% from 2025 to 2030.
The Asia-Pacific market for fusion proteins is expected to grow from $9 billion in 2025 to reach $17.6 billion by the end of 2030, at a CAGR of 14.5% from 2025 to 2030.
Report Scope
The report provides an overview of the global fusion proteins market and analyzes market trends. It includes global revenue ($ million) for the base year 2024, estimated data for 2025 and forecast data from 2026 through 2030. The market is segmented based on type, route of administration, application and region.
According to type, the market is segmented into cytokine traps, peptide-based fusion proteins, receptor-based fusion proteins and others. Based on application, the market is segmented into ophthalmic conditions, autoimmune diseases, metabolic disorders and hematological diseases. Regarding the route of administration, the market is segmented into intravenous, subcutaneous, intravitreal and others. The report also focuses on regional segmentation, including North America, Europe, Asia-Pacific and the Rest of the World, focusing on major countries in these regions.
The report focuses on the major driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance developments and discusses pipeline activities and emerging technologies related to the market. The report concludes with an analysis of the competitive landscape and industry structure. It also includes a dedicated section featuring company profiles with detailed information about leading companies. The scope of the report focuses on Fc-fusion protein products.
Report Includes
92 data tables and 51 additional tables
An overview of the global market for fusion proteins (genetically engineered recombinant therapeutics)
Analyses of the global market trends, with historical market revenue data from 2022 to 2024, estimates for 2025, and projections of CAGRs through 2030
Estimates of the market size and revenue growth prospects, along with a corresponding market share analysis by ligand type, route of administration, application, and region
Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impacts of macroeconomic variables
Impact analysis of U.S. tariff laws, as well as use cases of AI adoption on the fusion proteins market
Insights derived from Porter's Five Forces model, as well as global supply chain analyses
Information on emerging trends and applications in diagnostics and research industries, ongoing research activities, newly approved products, and underlying clinical trials
Identification of the major companies involved in the production and modification of fusion proteins, and analysis of the competitive landscape of the market
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
A relevant patent analysis, featuring key granted and published patents
Analysis of the industry structure, including companies' market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
Profiles of the leading companies, including Regeneron Pharmaceuticals Inc., Bristol Myers Squibb Co., Lilly, Amgen Inc., and Sanofi
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Technology Background
The Advantages of Fc-Fusion Proteins
Porter's Five Forces Analysis in the Fusion Proteins Market
Macroeconomic Factors Analysis
Impact of U.S. Tariffs
Government Policies on Drug Prices
Geopolitical Factors
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Need to Improve Pharmacokinetic and Pharmacodynamic Properties of Existing Protein Drugs
Demand for Targeted Therapeutics
Market Restraints
Manufacturing Challenges
Side Effects and Immunogenicity Risks
Market Opportunities
Diagnostic Applications of Fusion Proteins
Label Expansions and Drugs with Extended Duration
Chapter 4 Emerging Technologies and Pipeline Analysis
Key Takeaways
Emerging Technologies
Antibody-Directed Enzyme Prodrug Therapy
Artificial Intelligence for Fusion Protein Engineering
Bifunctional Fusion Proteins for Cancer Therapy
Pipeline Analysis
Chapter 5 Market Segmentation Analysis
Segmental Breakdown
Market Analysis by Ligand Type
Key Takeaways
Cytokine Traps
Peptide-Based Fusion Proteins
Receptor-Based Fusion Proteins
Others
Market Analysis by Route of Administration
Key Takeaways
Subcutaneous
Intravitreal
Intravenous
Others
Market Analysis by Application
Key Takeaways
Ophthalmic Conditions
Autoimmune Diseases
Metabolic Disorders
Hematological Diseases
Others
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Key Takeaways
Industry Structure
Company Share Analysis of the Fusion Proteins Market
Strategic Analysis
Chapter 7 Sustainability in the Fusion Proteins Market: An ESG Perspective
